Lawmakers ask FDA to review Hims’ Super Bowl ad for ‘misleading’ patients

Taking stock of the drug industry, from the lab to the medicine chest

February 7, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Screen capture via Youtube STAT+ | Lawmakers ask FDA to review Hims' Super Bowl ad for 'misleading' patients Two senators wrote to the FDA Friday about the ad, which they said misleads patients about compounded weight loss drugs. By Mario Aguilar STAT+ | Experts fear disruptions at FDA as Trump offers buyouts and layoff reports swirl The FDA is always trying to staff up, and already struggles to fulfill some of its duties. By Lizzy Lawrence Opinion: FDA clinical trial inclusivity guidelines will be back As I've seen in my work with the FDA, clinical trial diversity guidelines are necessary to make sure medications are safe and effective for everyone. By Suzanne B. Robotti Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser